BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21322979)

  • 1. 32p-labeled thio-tepa absorption in normal rat bladders: potential guide for intravesical chemotherapy in bladder cancer.
    Puchner PJ; Veenema RJ; Tomashefsky P; Pinzus T; Tannenbaum T
    Urology; 1974 Jul; 4(1):33-6. PubMed ID: 21322979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravesical thio-tepa: a study of 3H-thymidine uptake in normal urothelium and FANFT-induced tumors in rats.
    Nieh PT; Daly JJ; Irwin RJ; Prout GR
    Invest Urol; 1979 May; 16(6):486-8. PubMed ID: 109416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ThioTEPA pharmacokinetics during intravesical chemotherapy: the influence of dose and volume of instillate on systemic uptake and dose rate to the tumour.
    Masters JR; McDermott BJ; Harland S; Bibby MC; Loadman PM
    Cancer Chemother Pharmacol; 1996; 38(1):59-64. PubMed ID: 8603453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. THE TREATMENT OF BLADDER TUMORS BY THE INTRAVESICAL INSTILLATION OF THIO-TEPA OR OF ACTINOMYCIN D.
    ESQUIVEL EL
    Acta Med Philipp; 1965; 1():124-6. PubMed ID: 14283247
    [No Abstract]   [Full Text] [Related]  

  • 5. THE TREATMENT OF BLADDER TUMORS BY THE INTRAVESICAL INSTILLATION OF THIO-TEPA OR OF ACTINOMYCIN D.
    ESQUIVEL EL
    Philipp J Surg Surg Spec; 1964; 19():332-7. PubMed ID: 14260308
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of intravesical thio-tepa on normal and tumor urothelium.
    Nieh PT; Daly JJ; Heaney JA; Heney NM; Prout GR
    J Urol; 1978 Jan; 119(1):59-61. PubMed ID: 413937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A longitudinal study of patients with superficial bladder carcinoma successfully treated with weekly intravesical thio-tepa.
    Nocks BN; Nieh PT; Prout GR
    J Urol; 1979 Jul; 122(1):27-9. PubMed ID: 110947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ThioTEPA pharmacokinetics during intravesical chemotherapy and the influence of Tween 80.
    Masters JR; McDermott BJ; Jenkins WE; Fenwick E; Shah PJ; Mundy AR; Loadman PM; Bibby MC
    Cancer Chemother Pharmacol; 1990; 25(4):267-73. PubMed ID: 1688515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intravesical chemotherapy for superficial bladder tumors].
    Ohmori H
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1557-62. PubMed ID: 6206797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphologic effects of thio-TEPA on mouse urothelium.
    Murphy WM; Soloway MS; Lin CJ
    Acta Cytol; 1977; 21(5):701-4. PubMed ID: 414498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absorption studies on intraluminal thio-tepa for topical cytostatic treatment of low-stage bladder tumors.
    Lunglmayr G; Czech K
    J Urol; 1971 Jul; 106(1):72-4. PubMed ID: 4998357
    [No Abstract]   [Full Text] [Related]  

  • 12. N,N',N''-triethylenethiophosphoramide (thio-TEPA) oxygenation by constitutive hepatic P450 enzymes and modulation of drug metabolism and clearance in vivo by P450-inducing agents.
    Ng SF; Waxman DJ
    Cancer Res; 1991 May; 51(9):2340-5. PubMed ID: 1707751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prophylactic use of thio-tepa and urokinase in transitional cell carcinoma of the bladder: a preliminary report.
    Hisazumi H; Uchibayashi T; Naito K; Misaki T; Miyazaki K
    J Urol; 1975 Sep; 114(3):394-8. PubMed ID: 806708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intravesical instillation of adriamycin and other antineoplastic agents].
    Matsumura Y
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):372-6. PubMed ID: 7184406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of intravenous and intravesical administration of chloro-aluminum sulfonated phthalocyanine for photodynamic treatment in a rat bladder cancer model.
    Bachor R; Flotte TJ; Scholz M; Dretler S; Hasan T
    J Urol; 1992 May; 147(5):1404-10. PubMed ID: 1569696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of intravesical instillation of Thio-Tepa on the recurrence rate of bladder tumors.
    Asahi T; Matsumura Y; Tanahashi T; Yoshimoto J; Kaneshige T; Fujita Y; Ohmori H
    Acta Med Okayama; 1980 Feb; 34(1):43-9. PubMed ID: 6446839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intravesical application of thio-tepa for preventing postoperative recurrence of bladder carcinoma].
    Zhang SX; Deng XZ; Tang XD
    Zhonghua Wai Ke Za Zhi; 1986 Aug; 24(8):486-7, 510. PubMed ID: 3102180
    [No Abstract]   [Full Text] [Related]  

  • 18. Single and sequential combination intravesical chemotherapy of murine bladder cancer.
    Soloway MS; Nissenkorn I; McCallum LW; Murphy WM
    Urology; 1982 Feb; 19(2):169-75. PubMed ID: 6800090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of intravesical thio-tepa in the management of non-invasive carcinoma of the bladder.
    Koontz WW; Prout GR; Smith W; Frable WJ; Minnis JE
    J Urol; 1981 Mar; 125(3):307-12. PubMed ID: 6782251
    [No Abstract]   [Full Text] [Related]  

  • 20. Intravesical therapy of low stage bladder carcinoma with mitomycin C: comparison of results in untreated and previously treated patients.
    Prout GR; Griffin PP; Nocks BN; DeFuria MD; Daly JJ
    J Urol; 1982 Jun; 127(6):1096-8. PubMed ID: 6806488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.